Word

Status

Pending

Status Code

688

Status Date

Tuesday, January 9, 2024

Serial Number

90662894

Mark Type

2000

Filing Date

Thursday, April 22, 2021

Published for Opposition

Tuesday, November 14, 2023

Trademark Owner History

D3 Bio (Wuxi) Co., Ltd. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the treatment of respiratory diseases, cancer, musculoskeletal diseases, gastrointestinal disease, diseases and disorders related to the immune system, central nervous system, and cardiovascular system; chemico-pharmaceutical preparations for the treatment of respiratory diseases, cancer, musculoskeletal diseases, gastrointestinal disease, diseases and disorders related to the immune system, central nervous system, and cardiovascular system; drugs for medical purposes, namely, pharmaceutical drug preparations for the treatment of respiratory diseases, cancer, musculoskeletal diseases, gastrointestinal disease, diseases and disorders related to the immune system, central nervous system, and cardiovascular system; pharmaceutical preparations for use in biomedicine; pharmaceutical drugs for the treatment of respiratory diseases; pharmaceutical drugs for the treatment of cancer; pharmaceutical preparation for treating musculoskeletal disorders; pharmaceutical preparation for treating gastrointestinal disease; pharmaceutical preparation for treating diseases and disorders related to the immune system; pharmaceutical preparation for the central nervous system; cardiovascular pharmaceutical drug preparation

The mark consists of three Chinese characters in red to the right of a rounded red zig-zag design centered on a red vertical line.
The color(s) red is/are claimed as a feature of the mark.
The non-Latin characters in the mark transliterate to "DeShengJi" and this means "Moral Rise Aid" in English.

Trademark Events

Jan 9, 2024

Noa E-Mailed - Sou Required From Applicant

Nov 14, 2023

Official Gazette Publication Confirmation E-Mailed

Nov 14, 2023

Published For Opposition

Oct 25, 2023

Notification Of Notice Of Publication E-Mailed

Oct 5, 2023

Approved For Pub - Principal Register

Oct 5, 2023

Examiner's Amendment Entered

Oct 5, 2023

Notification Of Examiners Amendment E-Mailed

Oct 5, 2023

Examiners Amendment E-Mailed

Oct 5, 2023

Examiners Amendment -Written

Jul 29, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Jul 29, 2022

Teas/Email Correspondence Entered

Jul 29, 2022

Correspondence Received In Law Office

Jul 27, 2022

Assigned To Lie

Jul 7, 2022

Teas Voluntary Amendment Received

Jul 5, 2022

Teas Response To Office Action Received

Jan 5, 2022

Notification Of Non-Final Action E-Mailed

Jan 5, 2022

Non-Final Action E-Mailed

Jan 5, 2022

Non-Final Action Written

Dec 17, 2021

Assigned To Examiner

Jul 29, 2021

Notice Of Design Search Code E-Mailed

Jul 28, 2021

New Application Office Supplied Data Entered

Apr 26, 2021

New Application Entered